/MJARF
MJARF Stock - MJardin Group, Inc.
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$0.00+0.00%
+$0.00 (+0.00%) • Dec 19
75
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.80
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for MJARF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.00 – $0.00
TARGET (TP)$0.00
STOP LOSS$0.00
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-3.22
52W High$0.00
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|
| Revenue | $11.44M | $26.70M | $27.51M | $19.94M | $3,143 |
| Gross Profit | $5.68M | $9.50M | $11.65M | $19.94M | $3,143 |
| Gross Margin | 49.7% | 35.6% | 42.4% | 100.0% | 100.0% |
| Operating Income | $-14,610,344 | $-58,894,212 | $-46,626,770 | $1.62M | $-84,494 |
| Net Income | $-34,840,534 | $-267,467,927 | $-84,248,245 | $1.49M | $-84,494 |
| Net Margin | -304.6% | -1001.9% | -306.3% | 7.5% | -2688.3% |
| EPS | $-0.30 | $-3.27 | $-2.07 | $0.24 | $-0.01 |
Company Overview
MJardin Group, Inc., through its subsidiaries, cultivates, harvests, processes, and sells cannabis products in Canada and the United States. The company also provides consulting services, including strategic capital and financing, project management services for cultivation, licensure support, facility design, systems implementation, facility and equipment leasing, construction oversight, facility ramp-up, and access to intellectual property held by the company to licensed cannabis operators with cultivation and retail businesses. It owns, manages, or advises on a portfolio of 32 cannabis operations. The company was founded in 2014 and is headquartered in Ontario, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
MJARFBeat Rate
29%
Last 7 quarters
Avg Surprise
-408.8%
EPS vs Estimate
Beats / Misses
2/5
Last 12 quarters
Latest EPS
$-0.18
Q4 2021
EPS Surprise History
Q1 20
No data
Q2 20
No data
Q3 20
-200.0%
$-0.09vs$-0.03
Q4 20
+900.0%
$0.08vs$0.01
Q1 21
+21.1%
$-0.03vs$-0.03
Q2 21
-2216.1%
$-0.18vs$-0.01
Q3 21
-222.9%
$-0.08vs$-0.02
Q4 21
-1023.7%
$-0.18vs$-0.02
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2024 | Aug 8, 2024 | — | — | — | — |
Q2 2024 | May 29, 2024 | — | — | — | — |
Q1 2024 | Feb 28, 2024 | — | — | — | — |
Q4 2023 | Nov 1, 2023 | — | — | — | — |
Q3 2023 | Aug 3, 2023 | — | — | — | — |
Q2 2023 | May 31, 2023 | — | — | — | — |
Q1 2023 | Mar 1, 2023 | — | — | — | — |
Q4 2022 | Nov 29, 2022 | — | — | — | — |
Q3 2022 | Sep 1, 2022 | — | — | — | — |
Q2 2022 | Jun 1, 2022 | — | — | — | — |
Q2 2022 | May 10, 2022 | $-0.02 | — | — | — |
Q4 2021 | Nov 3, 2021 | $-0.02 | $-0.18 | -1023.7% | ✗ MISS |
Q3 2021 | Jul 12, 2021 | $-0.02 | $-0.08 | -222.9% | ✗ MISS |
Q2 2021 | Apr 30, 2021 | $-0.01 | $-0.18 | -2216.1% | ✗ MISS |
Q1 2021 | Mar 31, 2021 | $-0.03 | $-0.03 | +21.1% | ✓ BEAT |
Q4 2020 | Nov 5, 2020 | $0.01 | $0.08 | +900.0% | ✓ BEAT |
Q3 2020 | Jul 14, 2020 | $-0.03 | $-0.09 | -200.0% | ✗ MISS |
Q2 2020 | Jun 15, 2020 | — | $-2.10 | — | — |
Q1 2020 | Mar 31, 2020 | — | $-0.07 | — | — |
Q4 2019 | Nov 25, 2019 | $-0.05 | $-0.11 | -120.0% | ✗ MISS |
Latest News
Loading news...
Frequently Asked Questions about MJARF
What is MJARF's current stock price?
MJardin Group, Inc. (MJARF) is currently trading at $0.00 per share. The stock has moved +0.00% today.
What is the analyst price target for MJARF?
No analyst price targets are currently available for this stock.
What sector is MJardin Group, Inc. in?
MJardin Group, Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is MJARF's market cap?
MJardin Group, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does MJARF pay dividends?
No, MJardin Group, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorALID
Allied Corp.
$0.00
Mkt Cap: $0.0B
APPB
Applied Biosciences Corp.
$0.00
Mkt Cap: $0.0B
CBDY
Target Group Inc.
$0.00
Mkt Cap: $0.0B
CNNA
Cann American Corp.
$0.00
Mkt Cap: $0.0B
CPMD
CannaPharmaRX, Inc.
$0.00
Mkt Cap: $0.0B
JWCAF
James E. Wagner Cultivation Corporation
$0.00
Mkt Cap: $0.0B
LVVEF
Yooma Wellness Inc.
$0.00
Mkt Cap: $0.0B
MODVQ
ModivCare Inc.
$0.02
Mkt Cap: $0.0B
MSTH
Mystic Holdings, Inc.
$0.01
Mkt Cap: $0.0B
OWPC
One World Products, Inc.
$0.03
Mkt Cap: $0.0B
Explore stocks similar to MJARF for comparison